Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Baylor-Henry Minnie, Director. Officer active across 2 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 12 filings have been recorded. Activity tracked since 30 June 2021. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
12 of 12 declarations
Minnie Baylor-Henry is a Board Member of Paratek Pharmaceuticals, Inc. and Lantheus Holdings, Inc. She provides her expertise in governance and strategy to the board. Her experience in the pharmaceutical sector allows her to provide valuable insights to board discussions.